N. C. Elliott

发表

Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical development.

F. Lombardo, A. Kalgutkar, E. Laird, 2006, Bioorganic & medicinal chemistry letters.

Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine.

T. Gootz, D. Mann, M. Hindahl, 1992, Journal of medicinal chemistry.

Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinase.

Dennis E Danley, P. Lemotte, M. Mansour, 2005, Journal of medicinal chemistry.

Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphthalene.

S. Toler, M. J. Cole, D. Thompson, 1998, Journal of medicinal chemistry.

Synthesis and Structure‐Activity Relationships of 7‐ Diazabicycloalkylquinolones, Including Danofloxacin, a New Quinolone Antibacterial Agent for Veterinary Medicine.

T. Gootz, D. Mann, M. Hindahl, 1992 .

Semisynthetic hygromycin A analogs: synthesis and anti-bacterial activity of derivatives lacking the furanose moiety.

B. H. Jaynes, N. C. Elliott, D. L. Schicho, 1992, The Journal of antibiotics.

Synthesis and vitro antibacterial activity of hygromycin a analogs modified at the C4′ aryl position

Christopher B. Cooper, C. Cooper, S. Hecker, 1993 .

Benzimidazolone p38 inhibitors.

C. Gabel, T. Carty, John T Barberia, 2004, Bioorganic & medicinal chemistry letters.

Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.

D. Danley, J. Pandit, E. Laird, 2005, Bioorganic & medicinal chemistry letters.